|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2882440 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13748243.6 |
| Date of filing the European patent application | 2013-08-05 | |
| (97) | Date of publication of the European application | 2015-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
| (46) | Date of publication of the claims translation | 2019-04-25 |
| (86) | Number | PCT/US2013/053619 |
| Date | 2013-08-05 |
| (87) | Number | WO 2014/025688 |
| Date | 2014-02-13 |
| (30) | Number | Date | Country code |
| 201261680473 P | 2012-08-07 | US |
| (72) |
CAPONIGRO, Giordano, US
STUART, Darrin, US
MOUTOUH-DE PARSEVAL, Laure, CH
|
| (73) |
Array Biopharma, Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Farmaciniai deriniai, apimantys B-Raf slopiklį, EGFR slopiklį ir nebūtinai PI3K-alfa slopiklį |
| PHARMACEUTICAL COMBINATIONS COMPRISING A B-RAF INHIBITOR, AN EGFR INHIBITOR AND OPTIONALLY A PI3K-ALPHA INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2025-07-10 | 13 | 289.00 EUR |
| 2026-08-05 |